Tag: Heart Attack
Renowned Tamil actor Daniel Balaji passes away at 48
In a sorrowful turn of events, the Tamil film industry has lost one of its celebrated actors, Daniel Balaji, who succumbed to a heart attack ... Read More
Farxiga : AstraZeneca gets FDA fast track status for heart failure after MI
AstraZeneca has secured fast track designation for Farxiga (dapagliflozin) in the US for its use in reducing the risk of hospitalization for heart failure (hHF) ... Read More
Lilly bags Trulicity FDA approval for reducing CV risk in type 2 diabetes patients
Trulicity FDA approval : Eli Lilly and Company (Lilly) has secured approval from the US Food and Drug Administration (FDA) for Trulicity (dulaglutide) to reduce ... Read More
CytoSorbents gets CytoSorb EU approval for removal of ticagrelor during CPB
CytoSorbents has secured approval from the European Union (EU) for its CytoSorb extracorporeal blood purification therapy for the removal of anti-platelet agent ticagrelor during surgery ... Read More
Amarin bags Vascepa FDA approval for reducing cardiovascular risk
Vascepa FDA approval : New Jersey-based Amarin has secured approval from the US Food and Drug Administration (FDA) for a new indication and label expansion ... Read More
Common signs of heart attack in women not to ignore
All knew that chest pain is the common signs of heart attack. In the real life the common symptoms of heart attack include other signs ... Read More
Wayne Pharmaceuticals launches Dr Wayne’s Aspirin in US
Wayne Pharmaceuticals has launched Dr Wayne’s Aspirin Tablets in the US in a bottle package containing 300 tablets, each having 81mg strength. Dr. Wayne’s Aspirin ... Read More
Lycopene Uses for Cardiovascular Diseases | Tomato Health Benefits
As per the research done by the scientists of Cambridge Theranostics Ltd, a biotech firm, lycopene pigment present in tomatoes protect us from cardiovascular diseases ... Read More
Amgen cholesterol drug Repatha bags FDA approval for preventing heart attack and stroke
Repatha FDA approval news : Repatha (evolocumab), the Amgen cholesterol drug has bagged the approval from the US Food and Drug Administration (FDA) for the ... Read More
Tigenix’ heart attack stem cell therapy trial delivers positive results
TiGenix has announced that its cardiac stem cell study assessing its heart attack stem cell therapy with AlloCSC-01 was successful in patients having the risk of ... Read More